Uploads
Contact
/
Login
Upload
Search Results for 'Abstract 323 An Open Label Dose Escalation Phase I Ii Study To Assess Safety Tolerability Im'
Phase I and Phase II trial design in
tatiana-dople
The Safety and Tolerability of CSL112, a Reconstituted, Inf
faustina-dinatale
ABSTRACT Introduction A dietary supplement combination program PHASE DIETS
tatiana-dople
How to Find and Participate in a GIST clinical trial
ellena-manuel
Evaluation of tolerability, pharmacokinetics, and anti-
pamella-moone
Phase I Trial Designs Jud Blatchford, PhD
faustina-dinatale
A Demonstration Open Label
jane-oiler
March 29, 2011
danika-pritchard
March 29, 2011
tatyana-admore
De-Escalation & Safety Practices
phoebe-click
Open-label
pamella-moone
An APC activator (IMP321 or LAG-3Ig) combined with anti-PD
yoshiko-marsland
Phase I trials: A New era in
mitsue-stanley
Safety Considerations in Phase 1 Trials
stefany-barnette
Phase I Study of Olaparib and Temozolomide, in patients with recurrent and/or metastatic
alexa-scheidler
Performance in Initiating and Delivering Clinical Research
tawny-fly
Safety , Tolerability, and Pharmacokinetics of Long-Acting Injectable
phoebe-click
Wntresearch
alexa-scheidler
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
pamella-moone
De-escalation versus escalation of antiplatelet therapy in elderly ACS patients: insight
debby-jeon
Not randomised Open-label
phoebe-click
Program Faculty
calandra-battersby
De-escalation Techniques Strategies for preventing the escalation of behavior in the school
min-jolicoeur
Alarming behaviour & radicalisation*
tatyana-admore
1
2
3
4
5
6